Document and Entity Information
Document and Entity Information | Feb. 28, 2023 |
Document And Entity Information [Line Items] | |
Entity Tax Identification Number | 00-0000000 |
Amendment Flag | false |
Entity Central Index Key | 0001841258 |
Document Type | 8-K |
Document Period End Date | Feb. 28, 2023 |
Entity Registrant Name | EUROPEAN BIOTECH ACQUISITION CORP. |
Entity File Number | 001-40211 |
Entity Incorporation State Country Code | E9 |
Entity Address, Address Line One | EPFL Innovation Park Building |
Entity Address, Postal Zip Code | 1015 |
Entity Address, City or Town | Lausanne |
Entity Address, Country | CH |
City Area Code | 41 |
Local Phone Number | 77 976 21 09 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Units Each Consisting Of One Class A Ordinary Share And One Third Of One Redeemable Warrant [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant |
Trading Symbol | EBACU |
Security Exchange Name | NASDAQ |
Capital Unit, Class A [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Class A ordinary shares, par value $0.0001 per share |
Trading Symbol | EBAC |
Security Exchange Name | NASDAQ |
Warrants Each Whole Warrant Exercisable For One Class A Ordinary Share At An Exercise Price Of 11.50 [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
Trading Symbol | EBACW |
Security Exchange Name | NASDAQ |